Skip to content
drillr.ai
Sign up

IDXX

IDEXX Laboratories, Inc.

NASDAQ · Healthcare · Medical - Diagnostics & Research · US

$532.70
+0.64%
Ask drillr

  • Aug 14, 2026, 18:03 UTC

    IDEXX Laboratories outlined at its 2026 Investor Day a pipeline of diagnostic, software, and AI offerings, including cancer tests, targeting a $45 billion global companion-animal testing opportunity.

    Source:

  • Aug 11, 2026, 11:00 UTC

    IDEXX launched the Catalyst proBNP Test, the first and only dual-species point-of-care NT-proBNP assay for cardiac assessment in dogs and cats, at its Westbrook, Maine facility.

    Source:

  • Aug 4, 2026, 10:30 UTC

    IDEXX Laboratories reported second quarter 2026 revenues of $1,217 million, up 10% as reported and 9% organic, with growth across its business segments.

    Source:

  • Jun 25, 2026, 00:00 UTC

    Jonathan J. Mazelsky was appointed as a Class II director of Insulet Corp, effective July 1, 2026.